• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕博利珠单抗检查点抑制剂治疗后发生的嗜酸性筋膜炎

Eosinophilic Fasciitis following Checkpoint Inhibitor Therapy with Pembrolizumab.

作者信息

Zampeli Evangelia, Zervas Eleftherios

机构信息

Rheumatology Department, Lefkos Stavros - The Athens Clinic, Athens, Greece.

7 Pulmonary Department and Central Bronchoscopic Unit "Christos Gagas" NHS, Athens Chest Hospital "Sotiria", Athens, Greece.

出版信息

Mediterr J Rheumatol. 2021 Dec 27;32(4):376-377. doi: 10.31138/mjr.32.4.376. eCollection 2021 Dec.

DOI:10.31138/mjr.32.4.376
PMID:35128334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8802204/
Abstract

With the increasing number of indications for checkpoint inhibitor therapy in cancer patients, rheumatology specialists are often involved in the diagnosis and management of immune-related adverse events (irAEs). The most common rheumatic irAEs are arthritis, sicca syndrome, polymyalgia rheumatica, and myositis. Eosinophilic fasciitis, an already rare rheumatic disease, is a very unusual rheumatic irAE. Eosinophilic fasciitis, whether idiopathic or checkpoint inhibitor-associated, has very particular clinical symptoms and findings, such as the orange peel skin appearance and the Groove sign, which the physicians need to be aware of and recognise timely in order to diminish morbidity.

摘要

随着癌症患者中检查点抑制剂治疗适应证的增加,风湿病专科医生常常参与免疫相关不良事件(irAE)的诊断和管理。最常见的风湿性irAE是关节炎、干燥综合征、风湿性多肌痛和肌炎。嗜酸性筋膜炎,一种本就罕见的风湿性疾病,是一种非常不寻常的风湿性irAE。嗜酸性筋膜炎,无论是特发性的还是与检查点抑制剂相关的,都有非常特殊的临床症状和表现,如橘皮样皮肤外观和沟槽征,医生需要及时了解并认识到这些,以降低发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df1/8802204/4951c7a2b2be/MJR-32-4-376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df1/8802204/4951c7a2b2be/MJR-32-4-376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df1/8802204/4951c7a2b2be/MJR-32-4-376-g001.jpg

相似文献

1
Eosinophilic Fasciitis following Checkpoint Inhibitor Therapy with Pembrolizumab.帕博利珠单抗检查点抑制剂治疗后发生的嗜酸性筋膜炎
Mediterr J Rheumatol. 2021 Dec 27;32(4):376-377. doi: 10.31138/mjr.32.4.376. eCollection 2021 Dec.
2
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.免疫检查点抑制剂治疗后嗜酸性筋膜炎:四例病例及文献复习。
Oncologist. 2020 Feb;25(2):140-149. doi: 10.1634/theoncologist.2019-0508. Epub 2019 Oct 15.
3
Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series.抗程序性死亡-1 抗体引起的风湿免疫相关不良事件及皮质类固醇对肿瘤反应影响的初步分析:病例系列研究。
Eur J Cancer. 2018 Dec;105:88-102. doi: 10.1016/j.ejca.2018.09.027. Epub 2018 Nov 13.
4
Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity.癌症检查点疗法的风湿免疫相关不良事件:一种新病种实体的病例系列
RMD Open. 2017 Mar 20;3(1):e000412. doi: 10.1136/rmdopen-2016-000412. eCollection 2017.
5
Rheumatic immune-related adverse events in patients on anti-PD-1 inhibitors: Fasciitis with myositis syndrome as a new complication of immunotherapy.抗 PD-1 抑制剂治疗患者的风湿免疫相关不良事件:肌炎综合征伴筋膜炎作为免疫治疗的一种新并发症。
Autoimmun Rev. 2018 Oct;17(10):1040-1045. doi: 10.1016/j.autrev.2018.05.002. Epub 2018 Aug 10.
6
Immune Checkpoint Inhibitor-Associated Scleroderma-Like Syndrome: A Report of a Pembrolizumab-Induced "Eosinophilic Fasciitis-Like" Case and a Review of the Literature.免疫检查点抑制剂相关硬皮病样综合征:一例帕博利珠单抗诱导的“嗜酸性筋膜炎样”病例报告及文献综述
Rheumatol Ther. 2020 Dec;7(4):1045-1052. doi: 10.1007/s40744-020-00246-z. Epub 2020 Oct 16.
7
Treatment of rheumatic adverse events of cancer immunotherapy.癌症免疫治疗的风湿性不良事件的治疗。
Best Pract Res Clin Rheumatol. 2022 Dec;36(4):101805. doi: 10.1016/j.berh.2022.101805. Epub 2022 Dec 18.
8
[Rheumatic immune adverse events related to immune checkpoint inhibitors-(IrAEs related to ICI)].与免疫检查点抑制剂相关的风湿免疫不良事件 - (与免疫检查点抑制剂相关的免疫相关不良反应)
Bull Cancer. 2021 Jun;108(6):643-653. doi: 10.1016/j.bulcan.2021.01.016. Epub 2021 Apr 24.
9
Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy.癌症免疫治疗中免疫检查点抑制剂引起的风湿性表现和疾病
Front Med (Lausanne). 2021 Nov 4;8:762247. doi: 10.3389/fmed.2021.762247. eCollection 2021.
10
Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy.与检查点抑制剂治疗相关的各种风湿性疾病的频率和分布。
Rheumatology (Oxford). 2019 Dec 1;58(Suppl 7):vii40-vii48. doi: 10.1093/rheumatology/kez297.

引用本文的文献

1
Eosinophilic Fasciitis: Current and Remaining Challenges.嗜酸性筋膜炎:现状与遗留挑战。
Int J Mol Sci. 2023 Jan 19;24(3):1982. doi: 10.3390/ijms24031982.
2
Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on F-FDG-PET/CT.病例报告:帕博利珠单抗诱导的嗜酸性筋膜炎,在F-FDG-PET/CT上有高FDG摄取。
Front Med (Lausanne). 2022 Dec 20;9:1078560. doi: 10.3389/fmed.2022.1078560. eCollection 2022.

本文引用的文献

1
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.免疫检查点抑制剂治疗后嗜酸性筋膜炎:四例病例及文献复习。
Oncologist. 2020 Feb;25(2):140-149. doi: 10.1634/theoncologist.2019-0508. Epub 2019 Oct 15.
2
Evolution of one systemic rheumatic disease into another: scleroderma evolving to eosinophilic fasciitis with myositis.一种系统性风湿性疾病演变为另一种疾病:硬皮病演变为伴肌炎的嗜酸性筋膜炎。
Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):149-150. Epub 2019 Sep 3.
3
Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis.
嗜酸性筋膜炎的诊断标准、严重程度分类和治疗指南。
J Dermatol. 2018 Aug;45(8):881-890. doi: 10.1111/1346-8138.14160. Epub 2017 Dec 13.
4
Eosinophilic fasciitis (Shulman disease).嗜酸性筋膜炎(舒尔曼病)。
Best Pract Res Clin Rheumatol. 2012 Aug;26(4):449-58. doi: 10.1016/j.berh.2012.08.001.
5
Eosinophilic fasciitis: spectrum of MRI findings.嗜酸性筋膜炎:MRI表现谱
AJR Am J Roentgenol. 2005 Mar;184(3):975-8. doi: 10.2214/ajr.184.3.01840975.